閆博士第二份報告中曝光的為中共站台的美國知名科學家

新聞簡述:閆博士2020年10月8日在 zenodo 發表的第二份報告中揭露出了幾位為 CCP 病毒「自然起源理論」站台的知名美國學者。他們在閆博士的第一份報告發表之後,紛紛出來「批駁」閆博士的研究。閆博士在第二份報告中用科學證據證明那些「中間宿主」的不存在,並積極應戰這些沒有良知的西方科學家們,並「正在準備點對點的回應,並將很快發表」對這些「批駁」的回應。本文將帶領讀者看一下閆博士的第二份報告中,是怎樣揭露這些為中共站台的科學家的。並讓讀者看看這些「知名」的科學家都有什麼樣的科學和官方背景。

圖片來源:VOG戰友之家設計組

1. 節選翻譯自閆博士第二份報告第四章

What also need to be held accountable are the individuals and groups within certain organizations and institutions in the fields of public health and academic research, who knowingly and collaboratively facilitated the CCP’s misinformation campaign and misled the world. On January 18th and 19th, 2020, Dr. Li-Meng Yan, then anonymously, first revealed that SARS-CoV-2 is of a laboratory origin78,116. Immediately afterwards, on January 20th, Dr. Zhengli Shi submitted her manuscript to Nature and reported the first fabricated virus, RaTG134. Since then, many virus fabrications have taken place and all of them were published as peer-reviewed articles on top scientific journals4-9. Subsequently, based on such reports, influential opinion articles promoting the natural origin theory have then been published by prominent scientists and international organizations on such and other high-profile platforms10,117-120.

同時應被追責的,還有供職於某些公共健康和學術研究領域的組織和機構的個人和團體。他們在知情的情況下,配合中共的虛假宣傳,誤導世界。2020年1月18日、19日,閆麗夢博士首次匿名披露SARS-CoV-2來自實驗室78,116。緊接著,在1月20日,石正麗博士向《自然》雜誌投稿,報告了第一個捏造的病毒RaTG134。此後,陸續的出現了很多關於捏造的病毒的文章,並且全部作為同行評議的文章發表在頂級科學期刊上4-9。隨後,基於這樣的報道,傑出科學家和國際組織在頂級期刊和其它高知名度的平台上發表了文章,推廣病毒自然起源論10,117-120

In contrast to the rigorous promotion of the natural origin theory, strict censorship has been placed by these and other journals on manuscripts discussing a possible laboratory origin of SARS-CoV-218,121. Our earlier report1, which was one of such manuscripts and published as a preprint article, also faced unfounded criticisms dressed as unbiased peer reviews from two groups of scientists led by Drs. Robert Gallo and Nancy Connell, respectively122,123 (our point-to-point responses are being prepared and will be published soon). As a result of this collaborative efforts, the public has been largely removed from the truth about COVID-19 and SARS-CoV-2, which has led to misjudgments, delayed actions, and greater sufferings of the global community. It is imperative to investigate the scientists, laboratories, institutions, and relevant collaborators responsible for the creation of SARS-CoV-2 and for the fabrications/cover-up. It is also imperative to investigate the relevant individuals in the WHO, at the relevant scientific journals, in the relevant funding agencies, and in other relevant bodies, which have facilitated the creation of SARSCoV-2 and the scientific cover-up of its true origin while under full awareness of the nature of these operations. Finally, it also needs to be investigated which ones of the scientists engaged in the promotion of the natural origin theory were purely misled by the scientific fraud and which ones were colluding with the CCP government.

與自然起源理論的謹慎宣傳形成鮮明對比的是,這些頂級期刊和其他期刊對討論SARS-CoV-2可能緣於實驗室的文章實行了嚴格的審查18,121。我們早先的報告就屬於這種情況1。即使以預印本的形式發表,我們同樣面對著由Robert Gallo和Nancy Connell博士122,123帶領的偽裝成不帶偏見的同行評議專家組的毫無根據的批評(我們正在準備點對點的回應,並將很快發表)。由於這種來自科學界的通力「配合」,使得公眾在很大程度上被排除在COVID-19和SARS-CoV-2的真相之外,這導致了錯誤的判斷、延遲的行動和國際社會更大的苦難。當務之急是要調查那些參與製造SARS-CoV-2病毒的相關科學家、實驗室、科研機構和合作者,追究他們捏造事實和掩蓋真相的責任。與此同時,務必調查世衛組織、科學期刊、資助機構和其他相關機構的相關人員,調查他們在對中共行為的本質有充分認知的情況下,依舊協助製造SARSCoV-2病毒並掩蓋病毒來源真相的行為。最後,還需要調查參與推廣病毒自然起源論的科學家們,哪些人是純粹被科學欺詐所誤導,哪些人則是與中共政府勾結。

相關的參考文獻:

[10] Andersen, K.G., Rambaut, A., Lipkin, W.I., Holmes, E.C. & Garry, R.F. The proximal origin of SARS-CoV-2. Nat Med 26, 450-452 (2020).
[117] Calisher, C. et al. Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19. Lancet 395, e42-e43 (2020).
[118] Liu, S.L., Saif, L.J., Weiss, S.R. & Su, L. No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2. Emerg Microbes Infect 9, 505-507 (2020).
[119] Collins, F. Genomic Study Points to Natural Origin of COVID-19. NIH Director’s Blog,
https://directorsblog.nih.gov/2020/03/26/genomic-research-points-to-natural-origin-of-covid-19/ (2020).
[120] WHO. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19).
https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf (2020).
[122] Warmbrod, K.L., West, R.M., Connell, N.D. & Gronvall, G.K. In Response: Yan et al Preprint Examinations of the Origin of SARS-CoV-2. John Hopkins Center for Health Security, https://www.centerforhealthsecurity.org/our-work/pubs_archive/pubs-pdfs/2020/200921-in-response-yan.pdf  (2020).
[123] Koyama, T., Lauring, A., Gallo, R. & Reitz, M. Reviews of “Unusual Features of the SARS-CoV-2 Genome Suggesting Sophisticated Laboratory Modification Rather Than Natural Evolution and Delineation of Its Probable Synthetic Route”. Rapid Reviews COVID-19, https://rapidreviewscovid19.mitpress.mit.edu/pub/78we86rp/release/2 (2020).

2. 南希·康奈爾博士(Nancy Connell, PhD

約翰·霍普金斯大學健康安全中心、彭博公共衛生學院教授

約翰霍普金斯大學的南希·康奈爾博士(Nancy Connell, PhD)批駁閆博士第一份報告的觀點請見閆博士第二份報告的引用文獻[122]。 她的大學官方介紹如下。

圖片來源: https://www.centerforhealthsecurity.org/our-people/connell/ (visited on 10/8/2020)

Nancy Connell, PhD

Senior Scholar, Professor

南希·康奈爾博士

資深學者,教授

Expertise: Bacterial genetics · biological weapons · biodefense · predator bacteria · microbial forensics

專長:細菌遺傳學·生物武器·生物防禦·捕食性細菌·微生物取證

電郵:[email protected]

Professional Profile 職業簡歷

Dr. Connell is a Senior Scholar at the Johns Hopkins Center for Health Security and a Professor in the Department of Environmental Health and Engineering at the Johns Hopkins Bloomberg School of Public Health. She is a microbial geneticist by training.

康奈爾博士是約翰·霍普金斯大學健康安全中心(以下簡稱中心)的高級學者,並且是約翰·霍普金斯大學,彭博公共衛生學院,環境衛生與工程系的教授。 她是經過專業訓練的微生物遺傳學家。

Dr. Connell’s work at the Center is focused on advances in life sciences and technology and their application to a number of developments in the areas of biosecurity, biosafety, and biodefense. Her research projects analyze novel biotechnologies that might have an impact in several areas, such as the implementation of Biological Weapons Convention and the development of global catastrophic biological risks in ecosystems. She recently completed a study of the development of surge capacity for medical countermeasure manufacturing and other response mechanisms in the event of global pandemics or global catastrophic events. She is an Associate Editor of the peer-reviewed journal Health Security.

康奈爾博士在中心的工作重點是生命科學和技術的進步及其在生物安全和生物防禦領域的許多發展中的應用。 她的研究項目分析了可能在多個領域產生影響的新型生物技術,例如《生物武器公約》的實施以及生態系統中全球災難性生物風險的發展。 她最近完成了一項研究,以應對全球大流行或全球災難性事件中,醫療對策製造業和其它應對機制的應對能力發展。 她是同行評審期刊《健康安全》的副編輯。

Dr. Connell is a member of the Board on Life Sciences, a member of the Committee on International Security and Arms Control, and a National Associate of the National Academies of Sciences, Engineering, and Medicine (NASEM). She has served on more than 15 NASEM committees, including Advances in Technology and the Prevention of Their Application to Next Generation Biowarfare Agents (2004), Trends in Science and Technology Relevant to the Biological and Toxin Weapons Convention (2010), and Review of the Scientific Approaches Used During the FBI’s Investigation of the 2001 Anthrax Letters (2011). She is currently chairing the NASEM components of a series of international science and technology workshops, supported by the European Union and the United Nations, designed to explore regional advances and activities related to implementation of the  Biological Weapons Convention.

康奈爾博士是「生命科學委員會」的成員、「國際安全與軍備控制委員會」的成員,並且是美國國家科學、工程和醫學研究院(NASEM)的國家助理。 她曾在超過15個 NASEM 委員會中任職,包括技術進步和防止將其應用於下一代生物戰劑(2004年),與生物和毒素武器公約有關的科學技術趨勢(2010年)以及在FBI對2001年炭疽熱信進行調查時使用的科學方法(2011年)。 她目前在歐洲聯盟和聯合國的支持下主持一系列國際科學和技術研討會的 NASEM 組成部分,旨在探討與執行《生物武器公約》有關的區域進展和活動。

Dr. Connell is a member of the US National Science Advisory Board for Biosecurity and the US Centers for Disease Control and Prevention Office of Public Health Preparedness and Response Biological Agent Containment Working Group. She has had a long-standing interest in the development of regulatory policies associated with biocontainment work and dual-use research of concern. In addition to biomedical research policy, Dr. Connell has considerable experience and interest in pedagogy, with a focus on ethics education and the responsible conduct of research. She chaired the Nuclear Regulatory Commission Standing Committee for Faculty Development for Education about Research with Dual Use Issues in the Context of Responsible Science and Research Integrity, which has conducted a series of workshops throughout the Middle East and North Africa over the past 5 years. These workshops seek to apply contemporary teaching and learning methodologies (“active learning”) to the challenge of increasing awareness among young scientists of the societal implications of their research. She has presented at workshops and meetings around the world on the interrelated issues of biocontainment, infectious disease research, research ethics, and dual-use research of concern.

康奈爾博士是美國國家生物安全科學咨詢委員會和美國疾病控制與預防中心(CDC)公共衛生防備和響應生物制劑遏制工作組的成員。她長期以來對與生物遏制工作和相關的雙重用途研究相關的監管政策的制定感興趣。除了生物醫學研究政策外,康奈爾博士在教育學方面具有豐富的經驗和興趣,重點是倫理教育和負責任的研究行為。她主持了負責任的科學與研究誠信背景下的核監管委員會教職員工發展常任委員會關於雙重用途問題的研究,該委員會在過去 5 年中在中東和北非舉辦了一系列研討會。這些講習班試圖將當代的教學方法(「主動學習」)應用於挑戰,以提高年輕科學家對其研究的社會意義的認識。她在世界各地有關生物遏制、傳染病研究、研究倫理和值得關注的研究的雙重用途的相關問題的研討會和會議上作了演講。

圖片來源:https://www.centerforhealthsecurity.org/our-work/pubs_archive/pubs-pdfs/2020/200921-in-response-yan.pdf

Before joining the Center, Dr. Connell was Professor and Director of Research in the Division of Infectious Disease in the Department of Medicine at Rutgers New Jersey Medical School (NJMS) and the Rutgers Biomedical Health Sciences. Her major research focus was antibacterial drug discovery in respiratory pathogens such as Mycobacterium tuberculosis and Bacillus anthracis. Dr. Connell chaired the Institutional Biosafety Committee of Rutgers University and directed the NJMS biosafety level three containment laboratory beginning in 1997. Her recent work has focused on the use of predatory bacteria as novel therapeutics for treatment of Gram-negative bacterial infections, including multidrug-resistant strains and select agents. Dr. Connell was continuously funded by the National Institutes of Health, the Department of Defense, the Defense Advanced Research Projects Agency, industry, and other sources from 1992 to 2018. She received a PhD in microbial genetics from Harvard University.

加入中心之前,康奈爾博士曾擔任新澤西州羅格斯醫學院和羅格斯生物醫學健康科學學院醫學系傳染病學教授兼研究主任。 她的主要研究重點是在呼吸道病原體(如結核分枝桿菌和炭疽芽孢桿菌)中發現抗菌藥物。 康奈爾博士從1997年開始擔任羅格斯大學機構生物安全委員會主席,並領導 NJMS 生物安全 P3 實驗室。她最近的工作重點是使用掠食性細菌作為治療革蘭氏陰性細菌感染的新型療法,包括多藥抗性菌株和選擇劑。 從1992年到2018年,康奈爾博士一直由美國國立衛生研究院(NIH),國防部(DOD),國防高級研究計劃局,工業和其它資源持續資助。她有哈佛大學微生物遺傳學博士學位。

3. 羅伯特·加洛博士(Robert Gallo, MD

馬里蘭大學人類病毒學研究所所長

身為 HIV 研究國際權威的馬里蘭大學的羅伯特·加洛博士(Robert Gallo, MD)批駁閆博士第一份報告的觀點請見閆博士第二份報告的引用文獻[123]。 他的大學官方介紹如下。

【Figure 3. 圖片來源: https://www.medschool.umaryland.edu/profiles/Gallo-Robert/】

Robert C. Gallo, MD

Homer and Martha Gudelsky Distinguished Professor in Medicine and Co-Founder & Director, Institute Of Human Virology (IHV)

Academic Title: Professor

羅伯特·蓋洛(馬里蘭州)

荷馬和瑪莎·古德斯基醫學傑出教授,人類病毒學研究所(IHV)聯合創始人兼所長

學術頭銜:教授

Primary Appointment: Medicine

Secondary Appointment(s): Microbiology and Immunology

Administrative Title: Director, Institute of Human Virology

Additional Title: Co-Founder & International Scientific Advisor, Global Virus Network (GVN); Head, Director’s Laboratory, Division of Infectious Agents and Cancer, IHV

主要職務:藥物

次級職務:微生物學與免疫學

行政職務:人類病毒研究所所長

其它職務:全球病毒網絡(GVN)的聯合創始人兼國際科學顧問; IHV傳染病和癌症部主任實驗室主任

Email 電郵: [email protected]

Location 地址: IHV, 725 W Lombard St.

Phone (Primary) 電話: (410) 706-8614

Fax 傳真: (410) 706-1952

Education and Training

Providence College, BA, Biology, 1959

Jefferson Medical College, MD, 1963

Clinical Clerkship, Yale University School of Medicine, 1963

Residency, University of Chicago, 1965

教育背景:

普羅維登斯學院,生物學學士學位,1959年

傑斐遜醫學院,醫學博士,1963年

耶魯大學醫學院臨床文員,1963年

1965年,芝加哥大學,住院醫

Biosketch 簡歷

Dr. Gallo is recognized internationally for his co-discovery of HIV as the cause of AIDS. As a biomedical research scientist, he since has spent much of his career working to eliminate AIDS and other viral chronic diseases. In the early 1980s, Gallo and his team also pioneered the development of the HIV blood test, which enabled healthcare labors to screen for the AIDS virus for the first time, leading to a more rapid diagnosis while simultaneously protecting patients receiving blood transfusions. His research also helped physicians develop HIV therapies to prolong the lives of those infected with the virus. His 1996 discovery that a natural compound known as chemokines can block the HIV virus and halt the progression of AIDS was hailed by Science magazine as one of that year’s most important scientific breakthroughs.

蓋洛博士因共同發現艾滋病毒而成為國際公認的艾滋病專家。 作為一名生物醫學研究科學家,他從那時起就致力於消滅艾滋病和其它病毒性慢性疾病。 在1980年代初期,蓋洛和他的團隊還率先開發了 HIV 血液測試技術,該技術使醫療保健工作者首次能夠篩查 AIDS 病毒,從而可以更快地進行診斷,同時保護接受輸血的患者。 他的研究還幫助醫生開發了 HIV 治療方法,以延長被該病毒感染者的壽命。 他在1996年的發現中發現,一種稱為趨化因子的天然化合物可以阻斷 HIV 病毒並阻止 AIDS 的發展,被《科學》雜誌譽為當年最重要的科學突破之一。

Before the AIDS epidemic, Gallo was the first to identify a human retrovirus and the only known human leukemia virus—HTLV—one of few known viruses shown to cause a human cancer. In 1976, he and his colleagues discovered Interleukin-2, which is a growth-regulating substance now used as therapy in some cancers and even AIDS. Then in 1986, he and his group discovered the first new human herpes virus in more than 25 years (HHV-6), which was later shown to cause an infantile disease known as Roseola.

在艾滋病流行之前,蓋洛是第一個識別人類逆轉錄病毒的人,也是唯一已知的人類白血病病毒HTLV – 少數已知會導致人類癌症的病毒之一。 1976年,他和他的同事發現了白介素-2(Interleukin-2),它是一種生長調節物質,目前已用於某些癌症甚至艾滋病的治療。 然後在1986年,他和他的小組發現了25年來第一個新的人類皰疹病毒(HHV-6),後來證明它會引起一種稱為 Roseola 的嬰兒疾病。

Today, Dr. Gallo’s work continues at the Institute of Human Virology (IHV), an institute of the University of Maryland School of Medicine that Dr. Gallo helped found in 1996. IHV is the first virology center of its kind, combining the disciplines of research, patient care and prevention programs in a concerted effort to speed the pace of progress. In 2011, Gallo co-founded the Global Virus Network to position the world to rapidly respond to new or re-emerging viruses that threaten mankind, to achieve collaboration among the world’s leading virologists, and to support next-generation training.

如今,蓋洛博士的工作繼續在1996年由蓋洛博士創立的馬里蘭大學醫學院人類病毒研究所(IHV)進行。IHV 是同類中的第一個病毒學中心,齊心協力地加速致力於綜合科學研究、患者護理和預防計劃。 在2011年,蓋洛共同創立了全球病毒網絡(Global Virus Network),以使世界迅速應對威脅人類的新病毒或新出現的病毒,實現全球病毒學家領袖之間的協作,並支持對下一代科學家的培訓。

Prior to becoming IHV director in 1996, Gallo spent 30 years at the National Institutes of Health’s National Cancer Institute, where he was head of its Laboratory of Tumor Cell Biology. Dr. Gallo has received numerous scientific honors and awards from around the world, holds 35 honorary doctorates, and has published nearly 1,200 papers.

在1996年成為 IHV 主任之前,蓋洛在美國國立衛生研究院(NIH)的國家癌症研究所(NCI)工作了30年,在那裡他擔任腫瘤細胞生物學實驗室的負責人。蓋洛博士獲得了來自世界各地的眾多科學榮譽和獎項,擁有35個榮譽博士學位,併發表了近1,200篇論文。

Dr. Gallo was the most referenced scientist in the world in the 1980s and 1990s, during which time he had the unique distinction of twice winning America’s most prestigious scientific award—the Albert Lasker Award in Medicine – in 1982 and 1986. He was ranked third in the world for scientific impact for the period 1983-2002 (PNAS, November 15, 2005, vol102, no.46, 6569-16572).

蓋洛博士是1980年代和1990年代世界上被引用次數最多的科學家,在此期間,他獲得了兩次獨特的殊榮,分別在1982年和1986年兩次獲得了美國最負盛名的科學獎 – 阿爾伯特·拉斯克醫學獎。 (1983年11月15日,PNAS,第102卷,編號46,6569-16572)。

Research/Clinical Keywords: HIV Virus, HIV prevention, HIV Vaccine, Innovative HIV Therapies, Human T cell Leukemia Virus/HTLV, Human Retroviruses, Viral Oncology

研究/臨床關鍵詞:HIV 病毒,HIV 預防,HIV 疫苗,創新的 HIV 治療,人類 T 細胞白血病病毒/ HTLV,人類逆轉錄病毒,病毒腫瘤學

圖片來源: https://rapidreviewscovid19.mitpress.mit.edu/pub/78we86rp/release/2

4. 查爾斯·H·卡希爾博士(Charles H. Calisher, PhD

科羅拉多州立大學獸醫與生物醫學學院教授

閆博士第二份報告中還點出了其他幾位在世界知名學府或組織的為中共的病毒「自然起源說」站台的科學家。其中包括科羅拉多州立大學的查爾斯·H·卡希爾博士(Charles H. Calisher, PhD)。他的文章請見閆博士第二份報告中的參考文獻[117]。

圖片來源:https://www.publichealth.columbia.edu/research/center-infection-and-immunity/charles-h-calisher-phd

Member, Center for Infection and Immunity

Professor, College of Veterinary Medicine & Biomedical Sciences, Colorado State University

感染與免疫中心成員

科羅拉多州立大學獸醫與生物醫學學院教授

Phone 電話: 970.491.2987 

Fax 傳真: 970.491.8707 

Email 電郵: [email protected]

EDUCATION & TRAINING

Philadelphia College of Pharmacy and Science, Philadelphia, PA, B.S. (Bacteriology)

University of Notre Dame, Notre Dame, IN, M.S. (Biology; Gnotobiotics)

Georgetown University School of Medicine, Washington, DC, Ph.D. (Microbiology)

教育背景:

賓夕法尼亞州費城,費城藥學與科學學院,科學學士學位 (細菌學)

聖母大學,科學碩士學位(生物學、生殖生物)

華盛頓特區喬治敦大學醫學院,科學博士學位(微生物學)

SCIENTIFIC INTERESTS

Ecology and epidemiology of rodent-borne viruses 

Arbovirus ecology and epidemiology

Viral diagnosis

Viral taxonomy

Viral evolution

Recent major research emphasis is on the ecology of hantaviruses. Long-term field studies of these viruses in their natural rodent hosts are expected to provide information leading to prevention and control of these human pathogens. Coincident and ancillary studies provide knowledge about the mammalian hosts of these viruses as well as providing information about other rodent-borne viruses and about the mammals themselves.

科研方向:

嚙齒動物傳播病毒的生態學和流行病學

蟲媒病毒生態學和流行病學

病毒診斷

病毒分類學

病毒進化

最近的主要研究重點是漢坦病毒的生態學。 這些病毒在其天然嚙齒動物宿主中的長期野外研究有望提供導致預防和控制這些人類病原體的信息。 巧合和輔助研究提供了有關這些病毒的哺乳動物宿主的知識,以及有關其他嚙齒動物傳播的病毒和哺乳動物本身的信息。

5. 弗朗西斯·科林斯博士(Francis Collins, M.D., Ph.D.)

美國國家衛生研究院(NIH)院長

另一位為 CCP病毒自然起源說站台的居然是美國國家衛生研究院(NIH)的主任,是福奇醫生(Dr. Tony Fauci)的上司。他的站台文章請見閆博士第二份報告中的參考文獻[119].

圖片來源:https://www.nih.gov/about-nih/who-we-are/nih-director/biographical-sketch-francis-s-collins-md-phd

Francis S. Collins, M.D., Ph.D. was appointed the 16th Director of the National Institutes of Health (NIH) by President Barack Obama and confirmed by the Senate. He was sworn in on August 17, 2009. On June 6, 2017, President Donald Trump announced his selection of Dr. Collins to continue to serve as the NIH Director. In this role, Dr. Collins oversees the work of the largest supporter of biomedical research in the world, spanning the spectrum from basic to clinical research. 

弗朗西斯·科林斯,醫學博士、科學博士,被巴拉克·奧巴馬(Barack Obama)總統任命為美國國立衛生研究院(NIH)的第16位主任,並獲得參議院的確認。他於2009年8月17日宣誓就職。2017年6月6日,唐納德·川普總統宣佈柯林斯博士繼續擔任 NIH 主任。 科林斯博士在此職位上監督著全球最大的生物醫學研究支持者的工作,其工作範圍從基礎研究到臨床研究。

Dr. Collins is a physician-geneticist noted for his landmark discoveries of disease genes and his leadership of the international Human Genome Project, which culminated in April 2003 with the completion of a finished sequence of the human DNA instruction book. He served as director of the National Human Genome Research Institute at NIH from 1993-2008.

柯林斯博士是一位遺傳學家,以其對疾病基因的里程碑式發現和對國際人類基因組計劃的領導而著稱。該計劃於2003年4月完成,並完成了人類 DNA 指導書的完成序列。從1993年至2008年,他擔任 NIH 國家人類基因組研究所的所長。

Before coming to NIH, Dr. Collins was a Howard Hughes Medical Institute investigator at the University of Michigan. He is an elected member of the National Academy of Medicine and the National Academy of Sciences, was awarded the Presidential Medal of Freedom in November 2007, and received the National Medal of Science in 2009. In 2020, he was elected as a Foreign Member of the Royal Society (UK) and was also named the 50th winner of the Templeton Prize, which celebrates scientific and spiritual curiosity.

在加入 NIH 之前,柯林斯博士曾是密歇根大學的霍華德·休斯醫學研究所研究員。他是美國國家醫學科學院和美國國家科學院的當選成員,於2007年11月被授予總統自由勳章,並於2009年獲得了美國國家科學勳章。2020年,他當選為美國醫學學會的外國會員。英國皇家學會(Royal Society, UK),並被提名為Templeton獎的第50個獲獎者,該獎旨在表彰科學和精神上的好奇心。

6. 編者總結

正如閆博士在報告中所說的,這些在科學界任職高位的科學家在知情的情況下,配合中共的虛假宣傳、誤導世界,必須被追責。由於他們通力「配合」,使得公眾被排除在真相之外,這導致了大眾錯誤的判斷、延遲了行動,造成了國際社會更大的苦難。現在世界上有上百萬人由於感染 CCP 病毒而死亡,上千萬人被 CCP 病毒折磨,數億計的人民受到經濟、心理上的無法彌補的創傷。這些殺人不見血的「科學家」們必須受到法律的嚴懲和終將受到全世界人民對他們世世代代的唾棄。

文章撰寫:【Isaiah4031】閆博士報告節選翻譯及校對:【Jamie(文胤)】【重生】圖:【VOG戰友之家設計組】編輯:【Isaiah4031】

戰友之家玫瑰園小隊出品

相關新聞:

https://test.gnews.org/zh-hant/357288/
1+
0 則留言
Inline Feedbacks
View all comments

熱門文章

Isaiah4031

“but those who hope in the Lord will renew their strength. They will soar on wings like eagles; they will run and not grow weary, they will walk and not be faint” 【Isaiah 40:31】 10月 08日